Northwestern Mutual Wealth Management
UTHR icon

Northwestern Mutual Wealth Management’s United Therapeutics UTHR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
629
+250
+66% +$141K ﹤0.01% 1777
2026
Q1 		$225K Buy
379
+4
+1% +$1.99K ﹤0.01% 1859
2025
Q4 		$183K Sell
375
-63
-14% -$29.3K ﹤0.01% 1915
2025
Q3 		$184K Sell
438
-5
-1% -$1.68K ﹤0.01% 1841
2025
Q2 		$127K Buy
443
+70
+19% +$20.9K ﹤0.01% 1917
2025
Q1 		$115K Buy
373
+30
+9% +$10.3K ﹤0.01% 1878
2024
Q4 		$121K Sell
343
-65
-16% -$23.9K ﹤0.01% 1846
2024
Q3 		$146K Buy
408
+119
+41% +$40.2K ﹤0.01% 1746
2024
Q2 		$92.1K Sell
289
-27
-9% -$7.15K ﹤0.01% 1859
2024
Q1 		$72.6K Buy
316
+56
+22% +$12.6K ﹤0.01% 1935
2023
Q4 		$57.2K Sell
260
-78
-23% -$18K ﹤0.01% 1999
2023
Q3 		$76.3K Buy
338
+142
+72% +$32.7K ﹤0.01% 1812
2023
Q2 		$43.3K Sell
196
-244
-55% -$54K ﹤0.01% 2036
2023
Q1 		$98.5K Buy
440
+244
+124% +$60.2K ﹤0.01% 1696
2022
Q4 		$54.5K Buy
196
+65
+50% +$16.4K ﹤0.01% 1884
2022
Q3 		$27K Sell
131
-25
-16% -$5.59K ﹤0.01% 2101
2022
Q2 		$37K Buy
156
+13
+9% +$2.64K ﹤0.01% 2019
2022
Q1 		$26K Sell
143
-2
-1% -$381 ﹤0.01% 2205
2021
Q4 		$31K Buy
145
+2
+1% +$393 ﹤0.01% 2165
2021
Q3 		$26K Buy
143
+3
+2% +$591 ﹤0.01% 2137
2021
Q2 		$25K Buy
140
+30
+27% +$5.71K ﹤0.01% 2107
2021
Q1 		$18K Hold
110
– – ﹤0.01% 2096
2020
Q4 		$17K Sell
110
-100
-48% -$13.1K ﹤0.01% 2027
2020
Q3 		$21K Buy
210
+85
+68% +$9.33K ﹤0.01% 1789
2020
Q2 		$15K Hold
125
– – ﹤0.01% 1798
2020
Q1 		$11K Sell
125
-26
-17% -$2.47K ﹤0.01% 1884
2019
Q4 		$13K Hold
151
– – ﹤0.01% 1869
2019
Q3 		$12K Sell
151
-10
-6% -$805 ﹤0.01% 1886
2019
Q2 		$13K Sell
161
-65
-29% -$6.08K ﹤0.01% 1880
2019
Q1 		$27K Buy
226
+50
+28% +$5.83K ﹤0.01% 1599
2018
Q4 		$19K Sell
176
-23
-12% -$2.67K ﹤0.01% 1616
2018
Q3 		$24K Hold
199
– – ﹤0.01% 1589
2018
Q2 		$22K Buy
199
+41
+26% +$4.51K ﹤0.01% 1569
2018
Q1 		$17K Sell
158
-9
-5% -$1.14K ﹤0.01% 1595
2017
Q4 		$24K Sell
167
-9
-5% -$1.14K ﹤0.01% 1448
2017
Q3 		$21K Buy
176
+1
+0.6% +$128 ﹤0.01% 1453
2017
Q2 		$22K Hold
175
– – ﹤0.01% 1360
2017
Q1 		$24K Sell
175
-51
-23% -$7.73K ﹤0.01% 1272
2016
Q4 		$34K Buy
226
+4
+2% +$511 ﹤0.01% 1158
2016
Q3 		$27K Sell
222
-56
-20% -$6.73K ﹤0.01% 1162
2016
Q2 		$30K Sell
278
-137
-33% -$15.3K ﹤0.01% 1042
2016
Q1 		$46K Buy
415
+281
+210% +$35.6K ﹤0.01% 925
2015
Q4 		$20K Hold
134
– – ﹤0.01% 1006
2015
Q3 		$17K Sell
134
-37
-22% -$5.93K ﹤0.01% 972
2015
Q2 		$30K Sell
171
-41
-19% -$7.38K ﹤0.01% 788
2015
Q1 		$37K Sell
212
-17
-7% -$2.59K ﹤0.01% 721
2014
Q4 		$30K Buy
+229
New +$29.5K ﹤0.01% 778

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Northwestern Mutual Wealth Management's UTHR Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its United Therapeutics (UTHR) stake by 66% in Q2 2026, buying an estimated $141K and bringing the position to 629 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Northwestern Mutual Wealth Management first reported a position in UTHR in Q4 2014 and has held it in 47 quarters since. 876 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Northwestern Mutual Wealth Management held 629 shares of United Therapeutics worth $341K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 250 United Therapeutics shares in Q2 2026, an estimated $141K.
  • United Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1777 holding.
  • Northwestern Mutual Wealth Management first reported a position in United Therapeutics in Q4 2014 and has held it in 47 quarters since.
  • 876 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.